Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Monnien

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Clinical Colorectal Cancer|October 23, 2012
Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancerErion Dobi, Franck Monnien, Stefano Kim, et al.
Frontiers in Oncology|October 31, 2022
Prognostic role of HPV integration status and molecular profile in advanced anal carcinoma: An ancillary study to the epitopes-HPV02 trialAlice Debernardi, Aurélia Meurisse, Jean-Luc Prétet, et al.
BMC Cancer|December 31, 2013
Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levelsStefano Kim, Erion Dobi, Marine Jary, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 14, 2015
Prognostic value of angiopoietin-2 for death risk stratification in patients with metastatic colorectal carcinomaMarine Jary, Dewi Vernerey, Thierry Lecomte, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2016
Human papillomaviruses in colorectal cancers: A case-control study in western patientsLucine Vuitton, Carine Jaillet, Elise Jacquin, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 16, 2023
Evaluation of immune infiltrate according to the HER2 status in colorectal cancerChloé Molimard, Fanny Dor, Alexis Overs, et al.
Brain Pathology (Zurich, Switzerland)|May 6, 2017
Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysisArnault Tauziede-Espariat, Béatrice Parfait, Aurore Besnard, et al.
Cells|December 20, 2018
<i>ATG9A</i> Is Overexpressed in Triple Negative Breast Cancer and Its In Vitro Extinction Leads to the Inhibition of Pro-Cancer PhenotypesAurore Claude-Taupin, Leïla Fonderflick, Thierry Gauthier, et al.
Oncoimmunology|January 23, 2025
Liver metastases of colorectal cancer contain different subsets of tissue-resident memory CD8 T cells correlated with a distinct risk of relapse following surgerySyrine Abdeljaoued, Alexandre Doussot, Marie Kroemer, et al.
Clinical Breast Cancer|July 7, 2024
Prognostic Factors for Long-Term Eribulin Response in a Cohort of Patients With HER2-Negative Metastatic Breast CancerAntoine El Kaddissi, Dewi Vernerey, Antoine Falcoz, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Clinical Colorectal Cancer|October 23, 2012
Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancerErion Dobi, Franck Monnien, Stefano Kim, et al.
Frontiers in Oncology|October 31, 2022
Prognostic role of HPV integration status and molecular profile in advanced anal carcinoma: An ancillary study to the epitopes-HPV02 trialAlice Debernardi, Aurélia Meurisse, Jean-Luc Prétet, et al.
BMC Cancer|December 31, 2013
Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levelsStefano Kim, Erion Dobi, Marine Jary, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 14, 2015
Prognostic value of angiopoietin-2 for death risk stratification in patients with metastatic colorectal carcinomaMarine Jary, Dewi Vernerey, Thierry Lecomte, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2016
Human papillomaviruses in colorectal cancers: A case-control study in western patientsLucine Vuitton, Carine Jaillet, Elise Jacquin, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 16, 2023
Evaluation of immune infiltrate according to the HER2 status in colorectal cancerChloé Molimard, Fanny Dor, Alexis Overs, et al.
Brain Pathology (Zurich, Switzerland)|May 6, 2017
Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysisArnault Tauziede-Espariat, Béatrice Parfait, Aurore Besnard, et al.
Cells|December 20, 2018
<i>ATG9A</i> Is Overexpressed in Triple Negative Breast Cancer and Its In Vitro Extinction Leads to the Inhibition of Pro-Cancer PhenotypesAurore Claude-Taupin, Leïla Fonderflick, Thierry Gauthier, et al.
Oncoimmunology|January 23, 2025
Liver metastases of colorectal cancer contain different subsets of tissue-resident memory CD8 T cells correlated with a distinct risk of relapse following surgerySyrine Abdeljaoued, Alexandre Doussot, Marie Kroemer, et al.
Clinical Breast Cancer|July 7, 2024
Prognostic Factors for Long-Term Eribulin Response in a Cohort of Patients With HER2-Negative Metastatic Breast CancerAntoine El Kaddissi, Dewi Vernerey, Antoine Falcoz, et al.
Pageof 6